Testosterone Cypionate — Discount Pricing

Other medications in Hormones

• Testosterone Gel
• Anastrozole
• Cabergoline
• Clomiphene
• Conjugated Estrogens
• Desmopressin
• Estradiol
• Fludrocortisone

About Testosterone Cypionate

Testosterone cypionate is a prescription medication used to treat low testosterone levels in men. This injectable hormone therapy can help restore energy, muscle mass, and sexual function. If you're taking testosterone cypionate, TheDrugClub membership can help you access this medication affordably with $0 co-pays and free home delivery.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Testosterone Cypionate is approved for (FDA label)

DEPO-Testosterone Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. 1. Primary hypogonadism (congenital or acquired)-testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. 2. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Safety and efficacy of DEPO-Testosterone (testosterone cypionate) in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.

Source: Read the full FDA label on DailyMed. Label effective date: August 21, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Testosterone Cypionate (FDA label)

The following adverse reactions in the male have occurred with some androgens: Endocrine and urogenital: Gynecomastia and excessive frequency and duration of penile erections. Oligospermia may occur at high dosages. Skin and appendages: Hirsutism, male pattern of baldness, seborrhea, and acne. Cardiovascular Disorders: myocardial infarction, stroke. Fluid and electrolyte disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates. Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests, rarely hepatocellular neoplasms and peliosis hepatis (see WARNINGS ). Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia. Nervous system: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia. Allergic: Hypersensitivity, including skin manifestations and anaphylactoid reactions.

Source: FDA prescribing information (DailyMed). Set ID: cfbb53d4-b868-4a28-8436-f9112eb01c39. SPL document ID: 90ecbfeb-c0c6-4c34-94ff-591ee2fe2294. Label effective date: August 21, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Testosterone Cypionate (FDA label)

1. Known hypersensitivity to the drug 2. Males with carcinoma of the breast 3. Males with known or suspected carcinoma of the prostate gland 4. Women who are pregnant (see PRECAUTIONS, Pregnancy ) 5. Patients with serious cardiac, hepatic or renal disease (see WARNINGS )

Source: FDA prescribing information (DailyMed). Set ID: cfbb53d4-b868-4a28-8436-f9112eb01c39. SPL document ID: 90ecbfeb-c0c6-4c34-94ff-591ee2fe2294. Label effective date: August 21, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.